Stock Trend Analysis Report
Prepared for you on Tuesday, July 5, 2022.
Altamira Therapeutics Ltd. - Common Shares (NASDAQ:CYTO)
Long-Term Downtrend (-90) - CYTO is in a strong downtrend that is likely to continue. While CYTO is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid CYTO?
MarketClub looks at technical strength and momentum to determine if the timing is right for CYTO.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for CYTO
The long-term trend has been DOWN since Jun 10th, 2022 at 0.6208
The intermediate-term trend has been DOWN since Apr 18th, 2022 at 0.9494
The short-term trend has been DOWN since Jun 28th, 2022 at 0.5200
Smart Scan Analysis for CYTO
Based on our trend formula, CYTO is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|52wk High||3.87||52wk High Date||2021-08-03|
|52wk Low||0.451||52wk Low Date||2022-06-30|
|Average Volume||545,287||Shares Outstanding||11,417|